Summary:
Have a loved one with Alzheimer's disease? A new clinical trial is now looking for patients who are 55 to 85 years of age and live within the US. You must be willing to participate for at least 8 months.
Athira Pharma is running a phase 2/3 trial to evaluate the safety and effectiveness of a potential new treatment.
In order to qualify, you must be:
- Diagnosed with Alzheimer’s disease
- 55 to 85 years of age
- Living in the US
- Able to participate in 8 study visits over 8 months
Please note that study-related costs, including those associated with travel to the study clinic, will be reimbursed - you can speak with your site coordinator to learn more about the details.